Israel Active

The Israel Chamber of Commerce hosted a special seminar titled Israeli Medical Tourism and Women Empowerment at the Israeli Business and Cultural Center in Beijing.  China is impressed with Israel’s physicians, its high-quality healthcare, and advanced medical facilities.

Israel’s NeuroRx won the startup completion at the IATI Biomed conference in Tel Aviv for its Cuclurad treatment for depression and suicide symptoms.  The popular event included some 500 Business to Business meetings between Israeli and Chinese delegates.

Tel Aviv University Professor Hayit Greenspan has developed a wide variety of “deep learning” tools to facilitate computer-assisted diagnosis of X-rays, CTs and MRIs, freeing radiologists to attend to complex cases that require their full attention and skills.

Israel’s LifeSeal, the no-leak sealant solution for patients who have undergone gastrointestinal (GI) surgery , has received CE approval for use in the European Union.  LifeSeal has also been fast-tracked for approval by the US FDA through its Expedited Access Pathway (EAP)

Social work students from Yeshiva University’s Wurzweiler School of Social Work are in Israel to attend an intensive course on trauma, emergency response and recovery.  It features workshops on trauma intervention, and real-time emergency response simulation.

Israel’s Technion and New York University’s Langone Medical Center have begun a research project, targeting metastatic melanoma and mesothelioma.  They will test the ability of a nanotechnology based on so-called “nanoghosts” using stem cells to home in on cancer cells.

The DNA diagnostic breakthrough from the Hebrew University of Jerusalem has been funded.  Priority is now for a diagnostic tool for neurodegenerative, cardiovascular and autoimmune diseases plus a blood test for the early detection of multiple diseases at their asymptomatic stage.

The US medical organization Mayo Clinic is launching the Mayo Clinic Israeli Startups Initiative. It will encourage collaboration among Israeli health care startup companies and Mayo Clinic and fund joint R&D to accelerate availability of medical innovations to the public.

The SightDX Parasight Malaria Detection Platform from Israel’s Sight Diagnostics is to be introduced into India.  Approximately 880,000 cases of malaria were reported in India in 2013.

Israeli biotech Oramed has reported success in the Phase IIb study of its insulin capsule.  Oramed highlighted that it was the first time an oral solution showed a significant drop in blood sugar at night.  Oral insulin will replace injected delayed-release insulin.